Tranzyme, Inc. (TZYM) Reports In-Line Q1 Loss of 34c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Wall St slides as hot CPI data fuels rate-hike bets; chips, banks weigh
- Oil prices steady after gains on Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
Tweet
Share
E-mailGet Alerts TZYM Hot Sheet
Join SI Premium – FREE
Tranzyme, Inc. (NASDAQ: TZYM) reported Q1 EPS of ($0.34), in-line with the analyst estimate of ($0.34). Revenue for the quarter came in at $2.61 million versus the consensus estimate of $2.37 million.
For earnings history and earnings-related data on Tranzyme, Inc. (TZYM) click here.
For earnings history and earnings-related data on Tranzyme, Inc. (TZYM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
- Goldman Sachs (GS) Reiterated at Market Perform by Citizens on Earnings Opportunity
- StoneX Reiterates Buy Rating on HNI Corp (HNI)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
